Selected Flavonols in Breast and Gynecological Cancer: A Systematic Review
Selected Flavonols in Breast and Gynecological Cancer: A Systematic Review
Wendlocha et al., 2023 | Nutrients | Systematic Review
Citation
Wendlocha Dominika, Krzykawski Kamil, ... Kubina Robert. Selected Flavonols in Breast and Gynecological Cancer: A Systematic Review. Nutrients. 2023-Jun-28;15(13). doi:10.3390/nu15132938
Abstract
The consumption of foods that are rich in phenolic compounds has chemopreventive effects on many cancers, including breast cancer, ovarian cancer, and endometrial cancer. A wide spectrum of their health-promoting properties such as antioxidant, anti-inflammatory, and anticancer activities, has been demonstrated. This paper analyzes the mechanisms of the anticancer action of selected common flavonols, including kemferol, myricetin, quercetin, fisetin, galangin, isorhamnetin, and morin, in preclinical studies, with particular emphasis on in vitro studies in gynecological cancers and breast cancer. In the future, these compounds may find applications in the prevention and treatment of gynecological cancers and breast cancer, but this requires further, more advanced research.
Key Findings
In the future, these compounds may find applications in the prevention and treatment of gynecological cancers and breast cancer, but this requires further, more advanced research.
Outcomes Measured
- inflammatory markers
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Humans
- Female
- Flavonoids
- Flavonols
- Quercetin
- Antioxidants
- Breast Neoplasms
Evidence Classification
- Level: Systematic Review
- Publication Types: Systematic Review, Journal Article
- Vertical: quercetin
Provenance
- PMID: 37447264
- DOI: 10.3390/nu15132938
- PMCID: PMC10346890
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09